Paul Knight, Managing Director of CME Automation Systems analyses one of the biggest challenges facing the life sciences industry: how to implement automated ‘just-in-time’ clinical supply chains.
We hear from Don Riach, UK Operations Director at Biocair, who explores approaches to safe and sustainable delivery and next generation packaging for the life sciences sector.
Niall Balfour, Chief Executive Officer at Tower Cold Chain, explores the sustainability implications associated with both single-use, semi-reusable and fully reusable temperature-controlled shippers.
In our latest EPM Online Insight, Andy Clarke, Country Manager (UK), at YSDS explores the complexities and demands of low volume, high value shipments through specialist logistics support.
Niklas Adamsson, COO at Envirotainer explores the key trends set to shape the pharmaceutical cold chain in 2024 – a sector that carries an immense responsibility with lives depending on its success.
We caught up with LogiPharma's Will Robinson to discuss one of their recent sustainability reports, supply chains, and what the pharma world needs to prioritise throughout 2024.
Mohammed Samy, Head of Supply Chain at Pharmanovia looks to answer the question how can we future proof value chains to build resilience and agility without compromising our ESG efforts?
Adaptability, global collaboration, supply chain innovation and mRNA technologies were just some of the key trends in 2023. Rephine’s Dr. Eduard Cayón expects these themes to continue to develop and accelerate in 2024.
Bindiya Vakil, CEO and founder of Resilinc, is an award-winning expert in supply chain risk management who explores supply chain resiliency: a lifeline in the face of drug shortages in our latest EPM insights.
Timothy Korwan, Director of Technical Applications; Alex Joyner, Digital Lab Product Manager; and Sarah Ann Landry, Operations Manager, Fluid Handling Solutions, at Avantor discuss leveraging AI for inventory management of single-use solutions.
The biopharma industry has made minor strides toward improved resilience, but it’s not enough to meet future global demand for novel therapeutics. However, Ludovi Brellier, shows how to get there.
Karin Van Den Brekel who serves as Tower Cold Chain’s Regional Commercial Manager for EMEA, discusses the possibilities of reducing these risks by forming strategic alliances with expert cold chain shipping providers.
